QXO Inc (NYSE:QXO) Drops -83.38% In 2025; Is It Affordable At $16.27?

In last trading session, QXO Inc (NYSE:QXO) saw 2.62 million shares changing hands with its beta currently measuring 2.35. Company’s recent per share price level of $16.27 trading at $0.23 or 1.43% at ring of the bell on the day assigns it a market valuation of $8.44B. That closing price of QXO’s stock is at a discount of -1682.42% from its 52-week high price of $290.00 and is indicating a premium of 34.79% from its 52-week low price of $10.61.

QXO Inc (NYSE:QXO) trade information

Upright in the green during last session for gaining 1.43%, in the last five days QXO remained trading in the green while hitting it’s week-highest on Thursday, 05/15/25 when the stock touched $16.27 price level, adding 0.18% to its value on the day. QXO Inc’s shares saw a change of 2.33% in year-to-date performance and have moved 17.13% in past 5-day. QXO Inc (NYSE:QXO) showed a performance of 12.05% in past 30-days.

QXO Inc (QXO) estimates and forecasts

This year revenue growth is estimated to rise 4,392.47% from the last financial year’s standing.

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 13M for the same. And 1 analysts are in estimates of company making revenue of 14M in the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 55.18% during past 5 years.

QXO Inc (NYSE:QXO)’s Major holders

CITADEL ADVISORS LLC is the top institutional holder at QXO for having 9.3 million shares of worth $85.09 million. And as of 2024-06-30, it was holding 2.5922 of the company’s outstanding shares.

The second largest institutional holder is DRIEHAUS CAPITAL MANAGEMENT LLC, which was holding about 2.24 million shares on 2024-06-30. The number of shares represents firm’s hold over 0.6247 of outstanding shares, having a total worth of $20.49 million.

On the other hand, Advisor Managed Portfolios-Patient Opportunity Trust and T. Rowe Price Small-Cap Stock Fund, Inc. are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025, the former fund manager was holding 5.6 shares of worth $91.11 million or 1.25% of the total outstanding shares. The later fund manager was in possession of 4.82 shares on Dec 31, 2024, making its stake of worth around $78.46 million in the company or a holder of 1.08% of company’s stock.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.